Oligocide, a US-based company whose chemical kills bacteria (chlorea pictured), is preapring to potential raise its series A round with corporate venturing units. The compound was developed in partnership between University of New Mexico (UMN) and the University of Florida and Oligocide licensed it in June and received $175,000 in seed funding from angel investors…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.